TNFSF8 Polyclonal Antibody

TNFSF8 Polyclonal Antibody

Catalog Number:
A001514300RED
Mfr. No.:
RD89908A
Price:
$416
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Calculated MW: 26kDa
          Observed MW: 27kDa

          Please contact us at for specific academic pricing.

          Background

          The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF8/CD30, which is a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. The engagement of this cytokine expressed on B cell surface plays an inhibitory role in modulating Ig class switch. This cytokine was shown to enhance cell proliferation of some lymphoma cell lines, while to induce cell death and reduce cell proliferation of other lymphoma cell lines. The pleiotropic biologic activities of this cytokine on different CD30+ lymphoma cell lines may play a pathophysiologic role in Hodgkin's and some non-Hodgkin's lymphomas. Two transcript variants encoding different isoforms have been found for this gene.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human; mouse; rat
          Immunogen
          Recombinant fusion protein of human TNFSF8
          Purification
          Affinity purification
          Conjugate
          Unconjugated
          Formulation
          PBS with 0.02% sodium azide,50% glycerol,pH7.3.
          Storage
          Store at -20°C Valid for 12 months. Avoid freeze-thaw cycles.
          Concentration
          1mg/mL
          Antigen
          TNFSF8, CD153, CD30L, CD30LG, TNLG3A (Gene ID:944; UniProt:P32971)

          * For reference only.

      • Applications
        • Application
          WB
        • Application Dilutions
          WB 1:500-1:2000

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.